Leukemia Research
Volume 27, Issue 7 , Pages 617-626, July 2003

Dexrazoxane in combination with anthracyclines lead to a synergistic cytotoxic response in acute myelogenous leukemia cell lines

  • Michael Pearlman

      Affiliations

    • Departments of Leukemia and Special Medical Education Programs, M.D. Anderson Cancer Center, Unit 55, The University of Texas, 1515 Holcombe Boulevard, Houston, TX 77030, USA
  • ,
  • David Jendiroba

      Affiliations

    • Departments of Leukemia and Special Medical Education Programs, M.D. Anderson Cancer Center, Unit 55, The University of Texas, 1515 Holcombe Boulevard, Houston, TX 77030, USA
  • ,
  • Lance Pagliaro

      Affiliations

    • Department of Genitourinary Oncology, M.D. Anderson Cancer Center, Unit 427, The University of Texas, 1515 Holcombe Boulevard, Houston, TX 77030, USA
  • ,
  • Afsaneh Keyhani

      Affiliations

    • Departments of Leukemia and Special Medical Education Programs, M.D. Anderson Cancer Center, Unit 55, The University of Texas, 1515 Holcombe Boulevard, Houston, TX 77030, USA
  • ,
  • Baoshun Liu

      Affiliations

    • Departments of Leukemia and Special Medical Education Programs, M.D. Anderson Cancer Center, Unit 55, The University of Texas, 1515 Holcombe Boulevard, Houston, TX 77030, USA
  • ,
  • Emil J Freireich

      Affiliations

    • Departments of Leukemia and Special Medical Education Programs, M.D. Anderson Cancer Center, Unit 55, The University of Texas, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-713-792-2660; fax: +1-713-794-1812.

Received 11 June 2002; accepted 10 October 2002.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(02)00273-4

doi:10.1016/S0145-2126(02)00273-4

Leukemia Research
Volume 27, Issue 7 , Pages 617-626, July 2003